Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 2 | AAP PHARMA | Awarded | 1 | ₹97,650 |
| 2 | Schedule 4 | AAP PHARMA | Awarded | 1 | ₹32,445 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
27 Jul 2023, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
RADIO CONSUMABLES
5041498
GEM/2023/B/3700907
Two Packet Bid
RE-20,RE-20,RE-20,RE-20
30 days
Jammu And Kashmir; Srinagar
Item wise evaluation
BOQ
4 documents required · 4 mandatory
2 yrs
60%
Exempted
16 Aug 2023
17 Jul 2023
27 Jul 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | RE-20 | Non ionic Contrast Medium 0.5mml or ml for MRI inj Gadodiamide 10 ml prefilled syringe | 180 | N0 | sumit92 | 30 |
| 2 | RE-20 | Inj Gadobutrol 1.0 mml or ml vial of 10 ml | 60 | Vial | sumit92 | 30 |
| 3 | RE-20 | Inj Gadobenate dimeglumine 0.5 mmol or ml vial of 10 ml | 60 | Vial | sumit92 | 30 |
| 4 | RE-20 | Inj Gadoteric Acid 10 ml vial | 60 | Vial | sumit92 | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5041498.pdf
GEM_BID
bbqr-re-20_2023-07-17-09-27-45_4b6db7ea17e671a0a8d5bfaf04cddca8.pdf
BOQ
boq_item_sample_file_2022-06-16-20-09-46_7e07191983_2023-07-17-09-27-45_0c877c6f50403389dba9b810287d7967.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .